Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_provenance.
- befree-2016 importedOn "2016-02-19" NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_provenance.
- NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_assertion wasGeneratedBy ECO_0000203 NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_provenance.
- NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_assertion wasDerivedFrom befree-2016 NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_provenance.
- NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_assertion SIO_000772 19171333 NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_provenance.
- NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_assertion evidence source_evidence_literature NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_provenance.
- NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_assertion description "[To determine whether endometrial expression of the integrin alpha(v)beta(3) vitronectin can predict which endometriosis patient subgroup will benefit from pre-IVF cycle prolonged GnRH agonist (GnRHa) therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP716688.RAEqA3WQCK6t1P3qhP5UiJawmlnaFpRi64-aYsnmxMdxk130_provenance.